Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6DAK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,299
Award facts
- Contract value 100% obligated
- $21,299.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,299.00 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units). This firm fixed price, non-set-aside contract was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child delivery order under a larger vehicle, this award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to defense and veteran healthcare systems. The company's federal contracting profile demonstrates consistent success in competitive award competitions with the DLA Medical Supply Chain, with delivery orders reflecting firm fixed pricing across transaction values ranging from less than $100 to over $45,000. This particular award for Myrbetriq ER—a medication used in treating overactive bladder—represents routine pharmaceutical procurement fulfilling ongoing medical supply requirements for federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F6DAK?
SPE2DR26F6DAK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F6DAK worth?
The government has obligated $21,299 on SPE2DR26F6DAK.
Is contract SPE2DR26F6DAK an order under another contract?
Yes. SPE2DR26F6DAK is a delivery order under SPE2DR25D2213, an indefinite delivery contract.
Was contract SPE2DR26F6DAK competed?
The extent of competition for SPE2DR26F6DAK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award